 |
|
Funding for Biomedical Research
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
To the Editor: Several articles in the JAMA theme issue on medical research offer justifiably laudatory descriptions of the progress made in biomedical discovery. Yet many residents of the United States receive about half of the care they need for common conditions,1 die as a result of medical errors,2 or are driven into personal bankruptcy because of the costs of health care.3
Why is there a disconnect between the remarkable progress in biomedical research and the state of the care received in the United States? Dr Zerhouni4 notes the need for more clinical and translational research to speed the rate at which basic biomedical discoveries reach clinical application. However, another answer might be found in the article by Dr Moses and colleagues,5 who note that US health services research—research to understand and improve the delivery of health care—receives just 1.5% of the nation's investment in biomedical research, or approximately 0.1% . . . [Full Text of this Article]
Michael Seid, PhD
mseid@rand.org
Elizabeth A. McGlynn, PhD
RAND Corporation
Santa Monica, Calif
RELATED ARTICLES
Funding for Biomedical Research—Reply
Hamilton Moses, III, E. Ray Dorsey, David H. M. Matheson, and Samuel O. Thier
JAMA. 2006;295(9):1000-1001.
EXTRACT
| FULL TEXT
Funding for Biomedical Research
Joel Kupersmith and Jonathan Brian Perlin
JAMA. 2006;295(9):999-1000.
EXTRACT
| FULL TEXT
Financial Anatomy of Biomedical Research
Hamilton Moses, III, E. Ray Dorsey, David H. M. Matheson, and Samuel O. Thier
JAMA. 2005;294(11):1333-1342.
ABSTRACT
| FULL TEXT
|
